Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, and sepsis in children. Human immunity to pneumococcal infections has been assumed to depend on anticapsular antibodies. However, recent findings from murine models suggest that alternative mechanisms, dependent on T helper cells, are also involved. Although the immunological events in which T helper cells contribute to acquired immunity have been studied in mice, little is known about how these responses are generated in humans. Therefore, we examined bacterial and host factors involved in the induction of Th1 and Th17 responses, using a coculture model of human monocytes and CD4
Approximately one million children under 5 years of age die from infections caused by Streptococcus pneumoniae (the pneumococcus) every year according to the WHO (43) . This highly diverse human-specific bacterium causes a variety of diseases ranging from mild infections such as otitis media and sinusitis to diseases of greater severity such as pneumonia, septicemia, and meningitis. Invasive pneumococcal disease (IPD) is most common in young children, in the elderly, and in immunocompromised individuals. However, previously healthy adults may also suffer from IPD. Despite being a devastating pathogen, the pneumococcus is also a commensal of the human upper respiratory tract. Asymptomatic nasopharyngeal carriage is most prevalent in children under the age of 2 years, with up to 60% carriage rates in children attending day care centers (8, 45 ). An age-related decline is observed, with the lowest carriage rate in the adult population (9) . Repeated episodes of colonization may have an immunizing effect and confer protection against disease; however, little is known about the mechanisms behind development of natural immunity to pneumococci.
Acquisition of anticapsular antibodies is thought to provide protection against pneumococcal disease, which is illustrated by passive immunization strategies (17) and the use of vaccines based on pneumococcal capsular polysaccharides (22, 42) . Furthermore, the observation that patients with X-linked agammaglobulinemia and IgA deficiency suffer from bacterial infections, such as those caused by pneumococci, confirms the importance of antibodies (28) . However, epidemiological studies have suggested that mechanisms other than acquisition of anticapsular antibodies may also be important for the development of protection against pneumococcal infections. The age-related declines in pneumococcal disease among unvaccinated children in the United States were shown to be simultaneous for the seven most important serogroups, suggesting that acquisition of immunity involves a common, rather than serogroup-specific, mechanism (14) . Furthermore, only a small rise in anticapsular antibody concentrations was observed during this time period (14) . Also, in murine models of pneumococcal colonization, immunity was induced in the absence of antibody (19, 20, 38) . Hence, potential additional mechanisms have been proposed for the development of natural protection against pneumococci.
Several researchers have found that protection against pneumococcal carriage in mice involves a cellular immune response that requires the presence of CD4 ϩ T cells (19, 38) . Recently, the Th17 signature cytokine interleukin-17 (IL-17) was shown to represent a key component in pneumococcal immunity in mice (18, 46) . Immunization of mice with a whole-cell vaccine conferred protection against colonization via induction of IL-17A, and the proposed mechanism was IL-17-dependent neutrophil killing of pneumococci (18) . Moreover, in humans, the primary immunodeficiency disorder hyper-IgE syndrome, characterized by frequent infections by fungi as well as by extracellular bacteria such as Staphylococcus aureus and S. pneumoniae, was found to be linked to mutations in STAT3 and a subsequent loss of Th17 cells (23) , demonstrating the association between a defective Th17 response and a clinical phenotype. Taken together, these data support the concept that Th17 cytokines are involved in the host defense against pneumococci.
There are contradictory reports on the role of the Th1 cytokine gamma interferon (IFN-␥) in protection against pneumococcal infection (18, 27, 30, 32, 34, 35) . However, those investigators used murine models, and human T helper responses remain poorly understood. Interestingly, Kemp et al. found that IFN-␥-producing T cells disappear from the circulation in patients with pneumococcal pneumonia or bacteremia, suggesting that these cells are engaged in the in vivo immune response (10) . Furthermore, it has been demonstrated that peripheral blood mononuclear cells (PBMCs) from healthy adults living in a region with a high incidence of pneumococcal carriage and disease respond to pneumococcal antigens with both IFN-␥ and IL-17 production, indicating that exposure to pneumococci results in T cell-mediated immunological memory (25) .
Despite recent advances, the role of CD4 ϩ T cells in acquired cellular immunity remains poorly understood and the mechanisms by which pneumococci generate a T helper response in the human host have not been elucidated. Given the anticipated importance of Th17 cells in vaccine-induced immunity (reviewed in reference 13), further studies of humans are needed. In this study, we investigated bacterial as well as host factors affecting Th1 and Th17 responses to intact live pneumococci, using a coculture model of human monocytes and CD4 ϩ T cells. In addition, we also characterized the monocyte and T helper response to heat-killed pneumococci. We hypothesized that live and heat-killed pneumococci would induce differential levels of recognition by monocytes that, in turn, would promote distinct T helper cell responses. Our findings reveal that monocytes induce the production of Th1 and Th17 effector cytokines (IFN-␥ and IL-17, respectively) through multiple mechanisms and that bacterial viability determines the balance between the two immune effector arms.
MATERIALS AND METHODS
Reagents. Pam3Cys and muramyl dipeptide (MDP) were purchased from Invivogen, Escherichia coli lipopolysaccharide (LPS), cytochalasin D, and human serum were purchased from Sigma, and Candida albicans antigen was purchased from Greer Laboratories, Inc. (Lenoir, NC). Purified pneumococcal polysaccharides (types 2, 4, 9, and 14) were from Merck & Co. Recombinant human IL-12p70 was from R&D Systems, and IFN-␥ was from eBioscience. Neutralizing anti-human IL-12p40 monoclonal antibody (clone C8.6) and TLR2-blocking antibody (clone TL2.1) as well as the recommended isotype control were purchased from eBioscience.
Streptococcus pneumoniae strains and preparation of bacteria. Serotype 4 Streptococcus pneumoniae strain T4 (TIGR4; ATCC BAA-334) (36) and isogenic mutants deficient in the capsule (T4R; see reference 5) or pneumolysin (T4⌬ply; see reference 15) were used, as well as serotype 2 strain D39 (obtained from Peter Hermans, Rotterdam, The Netherlands) and clinical isolates of serotypes 9 (BHN60) and 14 (BHN78). Pneumococci were grown overnight on blood agar plates at 37°C, and colonies were inoculated into CϩY medium. The cultures were grown to mid-log phase (optical density at 620 nm [OD 620 ] of 0.5), pelleted by centrifugation, and diluted with cell culture medium prior to infection of cells. Bacteria were heat killed by incubation of cultures for 20 min at 90°C. Killing was confirmed by a negative count of viable bacteria on blood agar plates, and bacteria were stored at Ϫ20°C until they were used. For bacterial uptake assays, pneumococci were labeled with fluorescein isothiocyanate (FITC) solution (on ice for 30 min) and washed twice prior to infection of monocytes. At 1 h postinfection (p.i.), monocytes were washed twice and bacterial internalization was analyzed by flow cytometry. To quench extracellular bacterium-associated fluorescence, the cells were treated with trypan blue prior to flow cytometry analysis.
Peptidoglycan isolation. Insoluble peptidoglycan was isolated from nonencapsulated and autolysin-deficient S. pneumoniae strain T4R⌬lytA (5). Bacteria were grown in CϩY medium (Karolinska University Laboratory) to mid-log phase, harvested by centrifugation, and resuspended in cold saline solution. Lipids and lipophilic molecules were removed by boiling the bacteria in 4% sodium dodecyl sulfate (SDS) for 30 min and by extensive washing of the pelleted cells with saline solution, water, and acetone. The bacteria were then dried, resuspended in cold nonpyrogenic water, and broken in a French press operating at 1,000 lb/in 2 . Unbroken cells were sedimented by centrifugation at 1,500 ϫ g for 15 min, and cell walls were collected at 10,000 ϫ g for 30 min. Nucleic acids were degraded by enzymatic treatment with DNase I (50 g/ml) and RNase A (100 g/ml) for 18 h, and cell wall-attached proteins were digested with trypsin (200 g/ml) for 18 h. The enzymes were inactivated by boiling with 0.5% SDS, after which the cell walls were extensively washed with nonpyrogenic water and acetone and dried. For removal of cell wall-linked teichoic acid, the cell walls were treated with 10% trichloroacetic acid (TCA) at 22°C for 18 h (31). The cell walls were then washed with water and acetone and dried. Before use, the peptidoglycan was reconstituted to 4 mg/ml in nonpyrogenic water and briefly sonicated.
Isolation ) were cocultured in a 1:10 ratio (unless otherwise indicated) in 96-well flat-bottom plates. The cells were stimulated with pneumococcal peptidoglycan (1 g/ml), MDP (5 g/ml), LPS (100 ng/ml), or Pam3Cys (1 g/ml) or infected with heat-killed or live pneumococci (multiplicity of infection [MOI] of 10 per monocyte, unless otherwise specified). Each treatment for each donor was performed using triplicate wells. For the live pneumococcal infection, gentamicin (Invitrogen) (100 g/ml) was added after 30 min to kill extracellular bacteria. Controls included cultures of monocytes and CD4 ϩ T cells alone.
Stimulated cells were incubated at 37°C in a humidified atmosphere with 5% CO 2 . Supernatants were collected 5 days p.i. and stored at Ϫ20°C until assayed. As a positive control for determinations of IL-17 induction, cocultures were stimulated with Candida albicans antigen (20 g/ml). To skew the cytokine response, exogenous recombinant human IL-12p70 (1 ng/ml) and IFN-␥ (1 ng/ml) were added to the cultures. A neutralizing anti-human IL-12p40 antibody (10 g/ml) and a TLR2-blocking antibody and isotype control (20 g/ml) were used in some experiments. To inhibit or enhance bacterial uptake, monocytes were preincubated for 30 min with cytochalasin D (0.5 g/ml), and bacteria were opsonized with 10% human serum. Monocytes that were infected in the absence of CD4 ϩ T cells were incubated at 37°C in a humidified atmosphere with 5% CO 2 for 24 h. Supernatants were collected for IL-12p40 analysis using an enzyme-linked immunosorbent assay (ELISA), and cells were stained with fluorescently labeled antibodies against CD80 and CD86 (BD Biosciences) and analyzed by flow cytometry (FACSort; BD Biosciences). Assessment of cell viability. Cell viability was determined using an FITC annexin V apoptosis detection kit I (BD Biosciences). Cells were infected with heat-killed or live pneumococci (MOI of 1, 10, or 50 per monocyte) and stained 5 days p.i. with annexin V (apoptosis) and promidium iodide (necrosis) according to the manufacturer's instructions and analyzed by flow cytometry (FACSort; BD Biosciences).
Cytokine detection by ELISA. The collected supernatants from cocultures were assayed for IFN-␥ and IL-17 by the use of Ready-SET-Go! ELISA kits from eBioscience, and the monocyte supernatants were assayed for IL-12p40 by the use of an OptEIA ELISA set from BD. 
RESULTS
Human monocytes promote distinct patterns of Th1 and Th17 cytokines in response to heat-killed and live pneumococci. To investigate whether human monocytes could drive T helper cell responses to pneumococci, we measured levels of Th1 and Th17 signature cytokines IFN-␥ and IL-17 in the supernatant of cocultures of monocytes and CD4 ϩ T cells infected with serotype 4 strain T4. We found that a multiplicity of infection (MOI) of 10 promoted maximal levels of Th1 and Th17 effector cytokines at 5 days postinfection (p.i.) while causing minimal cell death (data not shown). Interestingly, bacterial viability had a critical impact on the balance between the two immune effector arms (Fig. 1A, B, D , and E). Whereas live pneumococci triggered high levels of IFN-␥, heat-killed pneumococci did not induce a significant upregulation of IFN-␥ compared to uninfected control results (Fig. 1A) . Notably, both live and heat-killed pneumococci induced a significant upregulation of IL-17 (Fig. 1B) , suggesting that Th1 and Th17 responses are induced by different mechanisms that are dependent on (Th1) or independent of (Th17) bacterial viability. To obtain further insight into the differences between live and heat-killed pneumococci with respect to T helperinducing capacity, we analyzed the effect of these bacterial preparations on monocyte activation. At 24 h p.i., monocytes infected with live pneumococci, but not monocytes infected with heat-killed pneumococci, expressed increased levels of the costimulatory molecules CD80 (data not shown) and CD86 (Fig. 1C) .
Interestingly, live pneumococci induced a dose-dependent upregulation of IFN-␥ (Fig. 1D) , whereas IL-17 levels reached a maximum at an MOI of 10 and decreased thereafter (Fig.  1E) . In contrast, an increased MOI of heat-killed pneumococci led to a dose-dependent upregulation of both IFN-␥ and IL-17 ( Fig. 1D and E) . This observation raised the issue of whether the presence of inhibitory factors produced by monocytes in response to the presence of live but not heat-killed pneumococci suppresses the production of IL-17. To test whether Th1-skewing conditions could influence the IL-17 response, we added exogenous recombinant IL-12p70 and IFN-␥ to the cocultures at the time of infection with a high MOI of heat-killed pneumococci (MOI of 50), a dose known to trigger substantial levels of IL-17 (Fig. 1E) . Addition of IL-12p70 led to a significant decrease in IL-17 levels (average, 30% of medium), whereas addition of IFN-␥ partially inhibited IL-17 levels (average, 73% of medium) (Fig. 1F) . The downregulation of IL-17 in response to IL-12p70 was coupled with a potent upregulation of IFN-␥ (data not shown), highlighting the role of this innate cytokine in establishing the Th1/Th17 balance. These data suggest that Th1-skewing conditions, induced by a live pneumococcal infection or by the addition of exogenous IL12p70, prevent induction of a Th17 response.
Different mechanisms are involved in the promotion of Th1 and Th17 responses. Because we observed that only a live infection induced a significant upregulation of IFN-␥, we speculated that this could have been due to enhanced uptake of live pneumococci by the activated monocytes, since intracellular bacteria presumably augment Th1 responses. To characterize the trigger of IFN-␥ production, we quantified uptake of FITClabeled pneumococci by monocytes by the use of flow cytometry. As expected, live bacteria were phagocytosed significantly more (average, 20-fold) than heat-killed bacteria ( Fig. 2A) . Moreover, in the presence of human serum, bacterial uptake increased further, while addition of cytochalasin D inhibited uptake (Fig. 2B) , indicating that uptake of pneumococci by monocytes is enhanced by antibody or complement opsonization and is dependent on actin polymerization. Importantly, opsonization of bacteria also enhanced IFN-␥ production whereas cytochalasin D treatment completely blocked the IFN-␥ response (Fig. 2C) , suggesting that the Th1 response is induced by the presence of internalized pneumococci. To investigate the contribution of monocyte-derived, Th1-promoting cytokines, we examined the IL-12 response at 24 h p.i. As shown in Fig. 2D , IL-12p40 was produced in response to live pneumococci but not in response to heat-killed pneumococci. Addition of an IL-12p40-neutralizing antibody strongly sup- (Fig. 2E) , indicating that the Th1 response is driven by monocyte-derived IL-12p40. We next analyzed the potential involvement of the pneumococcal capsule by assessing IFN-␥ expression in response to a live nonencapsulated isogenic mutant. Deletion of the polysaccharide capsule increased monocyte uptake of pneumococci (data not shown) and markedly enhanced IFN-␥ production compared to wild type (Fig. 2F) , providing further evidence that bacterial uptake favors a Th1 response. Conversely, the nonencapsulated mutant evoked a somewhat lower IL-17 response than the wild type (Fig. 2G ), in concordance with our previous finding that uptake of viable pneumococci is not required for the development of a Th17 response (Fig. 1B and  2A) . These results led us to speculate that heat-killed pneumococci might trigger IL-17 production by interacting with extracellular receptors. TLR2 is expressed on the extracellular plasma membrane and is one of the main receptors that recognize Gram-positive bacteria such as pneumococci (3, 11, 24, 33) . To test whether TLR2 is involved in IL-17 signaling, we preincubated cells with a TLR2-blocking antibody or isotype control prior to infection. Blocking TLR2 resulted in a significant reduction of IL-17 levels in response to heat-killed pneumococci (Fig. 2H) . However, the same antibody did not inhibit secretion of IL-17 or IFN-␥ in response to live pneumococci ( Fig. 2I and data not shown) , which suggests that live pneumococci primarily interact with intracellular receptors, which are not blocked by the anti-TLR2 antibody.
Pneumococcal peptidoglycan triggers T helper effector cytokines. Epidemiological studies have suggested that immunity to pneumococcal colonization and disease develops in a manner that is not specific for the pneumococcal capsular serotype (7, 14) . To assess whether different pneumococcal serotypes induce distinct T helper cytokine profiles in the same donor, we infected cocultures with strains belonging to four different pneumococcal serotypes (2, 4, 9V, and 14) and measured IFN-␥ and IL-17 levels in the supernatants. Each donor sample responded to these strains in a serotype-independent manner (data not shown). Moreover, purified polysaccharide capsules from the same four serotypes did not induce T helper cytokine production (data not shown). Thus, our data suggest that Th1 and Th17 responses might be triggered by a pneumococcal component common to all serotypes. One such component could be the cholesterol-dependent toxin pneumolysin, which is produced by virtually all clinical isolates of S. pneumoniae. Pneumolysin was recently shown to trigger IFN-␥ and IL-17 production in lungs of infected mice in an acute pneumonia model (21) . However, when we compared wild-type pneumococci with a pneumolysin-deficient mutant, we found no differences in the induction of IFN-␥ or IL-17 (Fig. 3A) . Consequently, in our system, Th1 and Th17 effector cytokines must have been induced by bacterial components other than pneumolysin. Possible bacterial components include cell wall fragments such as peptidoglycan and teichoic acid. We therefore stimulated our cocultures with purified pneumococcal peptidoglycan, and both IFN-␥ and IL-17 were indeed significantly upregulated (Fig. 3B) . Since remnants of cell wall teichoic acids may be present in the polymeric peptidoglycan preparation after treatment with trichloroacetic acid (TCA), which removes about 90% of the cell wall teichoic acids (31), we also assessed the cytokine response to a peptidoglycan preparation that had not been TCA treated and thus harbored intact cell wall teichoic acids. Importantly, this preparation induced similar levels of IFN-␥ and IL-17 (data not shown), suggesting that peptidoglycan and not teichoic acid is the elicitor of the cytokine responses. Interestingly, the IL-17 response to purified peptidoglycan at 1 g/ml was equivalent to that induced by intact pneumococci (Fig. 3B and 1B) . However, the IFN-␥ response to purified peptidoglycan was considerably lower than that induced by live pneumococci (Fig. 3B and 1A) . Peptidoglycan derivatives such as muramyl dipeptide (MDP) have been proposed to enhance T helper cytokine production in response to TLR signals (39, 41) . However, as with those previous reports, we observed that MDP by itself is unable to induce a cytokine response (Fig. 3B) . Furthermore, using the additional microbial ligands LPS and Pam3Cys, which are specific for TLR4 and TLR2, respectively, we observed an upregulation in both IFN-␥ and IL-17 production (Fig. 3B) . Together, these data indicate that monocytes stimulated with microbial ligands trigger distinct Th1/Th17 profiles. CD4 ؉ memory T cells produce IFN-␥ and IL-17 via interactions with monocytes. Previous studies have shown that memory T cells are the principal IL-17-secreting T cells (5, 16, 40) . To determine the predominant source of IFN-␥ and IL-17 in our system, we compared the T helper cytokine responses to monocytes cocultured with unfractionated and memory T helper cells. As expected, we observed higher levels of IFN-␥ and IL-17 in cocultures with CD4 ϩ memory T cells (Fig. 4A  and B) . As a control, we also stimulated the cocultures with C. albicans (Fig. 4C) , which has previously been shown to be a potent inducer of IL-17 from memory T helper cells (40) .
To evaluate the importance of monocytes in the induction of IFN-␥ and IL-17 by memory T helper cells, we cultured a fixed number of CD4 ϩ memory T cells together with decreasing numbers of monocytes (from 50% to 0.1%). We also infected cultures of CD4 ϩ memory T cells or monocytes alone. As shown in Fig. 4D , secretion of IFN-␥ strongly correlated with the number of monocytes in the coculture; a 50-fold decrease in monocytes (from 50% to 1%) led to a 40-fold drop in IFN-␥ release (from 16,000 to 400 pg/ml). Interestingly, the secretion of IL-17 did not follow the same pattern (Fig. 4E) . Decreasing the number of monocytes had no direct inhibitory effect on the level of IL-17 produced. In fact, not until the percentage of monocytes was less than 0.5% did the IL-17 level drop. Importantly, pneumococci were unable to induce either IFN-␥ or IL-17 in the absence of monocytes ( Fig. 4D and E) , demonstrating that T helper cells cannot respond directly to a pneumococcal infection.
DISCUSSION
Although the immunological events in which T helper cells contribute to acquired immunity have been studied in pneumococcal mouse models (18, 19, 46) , little is known about how these responses are generated in humans. In the present study we have characterized T helper cell responses to pneumococci in the human system. We demonstrate that monocytes infected with pneumococci regulate IFN-␥ and IL-17 production by memory T helper cells through multiple mechanisms.
Interestingly, the IFN-␥ response to live pneumococci was 100-fold higher than to heat-killed pneumococci, while the IL-17 response was not inhibited by heat killing. We observed that live pneumococci promoted enhanced uptake and activation of monocytes, with a subsequent high IFN-␥ response from cocultured CD4 ϩ T cells, whereas neither bacterial uptake nor monocyte activation was required for the induction of IL-17. Furthermore, monocyte secretion of IL-12p40 was observed only in response to live pneumococci but not to heatkilled pneumococci, and when this cytokine was blocked with a neutralizing antibody, IFN-␥ levels were markedly reduced, demonstrating that the Th1 response to live pneumococci is dependent on the presence of monocyte-derived IL-12p40. In a study by Yamamoto et al., the role of IL-12p40 in host resistance to S. pneumoniae infection was investigated using IL-12p40 knockout mice (44) . The researchers reported that IL-12p40 plays a critical role in the host defense by promoting IFN-␥-dependent recruitment of neutrophils to infected tissues. Our observation that the human Th1 response is dependent on bacterial viability provides a further insight into Th1-mediated host defense mechanisms in response to pneumococcal infections.
Surprisingly, the induction of a Th17 response was independent of bacterial viability. Heat-killed pneumococci were found to trigger IL-17 production via TLR2 signaling, in line with a recent report in which efficient clearance of pneumococcal colonization by IL-17-expressing CD4 ϩ T cells was shown to require TLR2 signaling (46) . However, in our in vitro system, the extracellular TLR2 was not involved in the cytokine response to live pneumococci. One possible explanation is that live pneumococci, which were internalized in greater numbers than heat-killed pneumococci, interact with intracellular pattern recognition receptors inside monocytes such as TLR9 and NOD2. This explanation is in accordance with data showing that the ability of pneumococci to activate NF-B through TLR9 is reduced by heat inactivation (24) . Similarly, Opitz et al. reported, that in contrast to viable pneumococci, heat-killed pneumococci fail to induce NF-B activation in NOD2-transfected cells (29) . Thus, it could be hypothesized that live pneumococci interact with multiple intracellular receptors, thereby synergistically inducing a strong Th1 response. Indeed, it has been shown that cross-talk between pattern recognition receptors, such as NOD1 in conjunction with TLRs, enhances the immunological response and contributes to the onset of adaptive immunity (6) .
To identify the bacterial factor(s) responsible for triggering production of IFN-␥ and IL-17, we examined the influence of various pneumococcal components, such as the capsule and the cytotoxin pneumolysin as well as the cell wall components peptidoglycan and teichoic acid, that are important for the interaction with host cells. We found that the cytokine response was independent of capsular type and that the capsule itself did not induce a response. Rather, our results show that pneumococcal peptidoglycan is a potent ligand for the generation of both Th1 and Th17 cytokines. Interestingly, we observed that purified peptidoglycan at 1 g/ml induced levels of IFN-␥ and IL-17 similar to those seen with heat-killed pneumococci at an MOI of 10. However, the same MOI of live pneumococci induced an IFN-␥ response that was much higher than that induced by purified peptidoglycan. These results suggest that, although peptidoglycan may be the bacterial ligand responsible for triggering T cell effector cytokines in response to heat-killed bacteria, a processing event or additional ligands may be involved in the immune recognition of live bacteria.
Recent findings suggest that dendritic cells (DCs) promote T helper cytokine production through activation of NOD2 by peptidoglycan derivatives such as MDP (39, 41) . Thus, it is possible that phagocytosed live pneumococci enhance the Th1 response by intracellular release of monomeric peptidoglycan that contains MDP epitopes that are recognized by cytoplasmic NOD2. The mechanisms underlying the internalization of MDP to the cytosol are unclear (12) . It is likely that the exogenously administered MDP was not internalized to the same extent as intact bacteria, which might explain the differences in IFN-␥ responses. Recognition of heat-killed pneumococci, on the other hand, seems to occur through extracellular receptors on monocytes. Those may include interactions between polymeric peptidoglycan and TLR2 (2, 41), although we cannot rule out the possibility that TLR2 senses minute amounts of lipoteichoic acid and lipopeptides in the purified peptidoglycan (37) . In contrast to reports demonstrating that pneumolysin induces IL-17 production from human tonsillar cells (18) and IFN-␥ and IL-17 release in a murine infection model (21), we found no differences between the wild-type strain and a pneumolysin-deficient mutant in either IFN-␥ or IL-17 induction. The discrepancy between our study and that by McNeela et al. (21) could be explained by the differences in the cellular sources for IFN-␥ and IL-17 (NK and ␥␦ T cells in the study by McNeela et al. as opposed to ␣␤ T cells in the present study) and host-specific differences in the response to pneumolysin. In fact, we have previously shown that, while pneumolysin triggers IL-1␤ secretion in murine DCs, it inhibits IL-1␤ in human DCs (15) . Furthermore, in agreement with our study, Mureithi and colleagues found that, although recombinant pneumolysin could induce IFN-␥ and IL-17 from human PBMCs, the responses seen with the wild type and a pneumolysin-deficient mutant did not differ (25) .
Our results suggest that the T helper cytokine response to pneumococci is mainly derived from CD45RO ϩ memory T helper cells. Reactivation of human Th1 and Th17 memory cells by TLR-activated antigen-presenting cells (APCs) has previously been demonstrated (1, 4, 39) . However, it is noteworthy that those investigators stimulated cells in the presence of superantigen or anti-CD3/anti-CD28 antibodies or used allogeneic T cells. In the present study, we investigated the T helper response in the absence of artificial mitogens, and we show for the first time that monocytes stimulated with pneumococcal peptidoglycan promote cytokine production by autologous CD4 ϩ T cells. One of the key observations in this study is the negative relationship between Th1 and Th17 cytokine responses. Exogenous addition of IFN-␥ or the Th1-skewing cytokine IL-12p70 led to inhibition of IL-17 production in response to heat-killed pneumococci, which corroborates previous reports suggesting that Th1 conditions negatively regulate IL-17 induction (4, 9, 26) . Hence, this regulatory function of Th1 cytokines may represent a negative-feedback system that counteracts exaggerated Th17-mediated inflammation and tissue destruction. A deeper understanding of the pathways that regulate these cytokines in humans could lead to the development of novel immunomodulatory therapies aimed at suppression of excessive mucosal inflammation. Insight into the generation of T helper responses in humans may also facilitate the design of pneumococcal vaccines based on cell-mediated immunity and provide a platform for detailed mapping of candidate genes or pathways among patients with increased susceptibility to pneumococcal infections. 
